SCHEMBL20298638

SCHEMBL20298638

CNCCCc1ccc(C(F)(F)F)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 3/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TRPV4 Q9HBA0 1/20 0.42
▸ TKT P29401 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP3A5 P20815 1/20 0.40
▸ PLAAT3 P53816 1/20 0.40
▸ PLAAT5 Q96KN8 1/20 0.40
▸ PLAAT2 Q9NWW9 1/20 0.40
▸ PLAAT4 Q9UL19 1/20 0.40
▸ KDM1A O60341 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.39
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ CYP2C19 P33261 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12224352 0.81 NFKB1 (0.50) DAOMEN1KMT2ATRPV4TKT
SCHEMBL18737245 0.80 RAB9A (0.48) DAOMEN1KMT2ATRPV4TKT
SCHEMBL297140 0.80 KDM1A (0.50) DAOTRPV4TKTCYP3A4CYP3A5
SCHEMBL15132153 0.79 DAO (0.46) DAOMEN1KMT2ATRPV4TKT
SCHEMBL21266578 0.79 RAB9A (0.50) DAOMEN1KMT2ATRPV4TKT
SCHEMBL991269 0.78 DAO (0.48) DAOTRPV4TKTPLAAT3PLAAT5
SCHEMBL5657097 0.78 DAO (0.48) DAOTRPV4TKTPLAAT3PLAAT5
SCHEMBL14028936 0.78 TKT (0.49) DAOMEN1KMT2ATRPV4TKT
SCHEMBL31067892 0.78 TKT (0.49) DAOMEN1KMT2ATRPV4TKT
SCHEMBL3851699 0.78 DAO (0.50) DAOMEN1KMT2ATRPV4TKT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558965-A1 NEW QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-10-30 — — EP claimed
CN-110248933-A Novel quinoline and isoquinoline derivatives for the treatment of pain and pain related disorders 埃斯特韦制药股份公司 2019-09-17 — — CN claimed
WO-2018115064-A1 NEW QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2018-06-28 — — WO claimed
EP-3558965-A1 NEW QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-10-30 — — EP disclosed
CN-110248933-A Novel quinoline and isoquinoline derivatives for the treatment of pain and pain related disorders 埃斯特韦制药股份公司 2019-09-17 — — CN disclosed
WO-2018115064-A1 NEW QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2018-06-28 — — WO disclosed
Send feedback